uk renal registry 16th annual report figure 12.1. percentage of haemodialysis patients with...
TRANSCRIPT
![Page 1: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/1.jpg)
UK Renal Registry 16th Annual Report
Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2012
![Page 2: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/2.jpg)
UK Renal Registry 16th Annual Report
Figure 12.2. Funnel plot of percentage of haemodialysis patientswith phosphate within the range specified by the RA clinical
audit measure (1.1–1.7 mmol/L) by centre in 2012
![Page 3: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/3.jpg)
UK Renal Registry 16th Annual Report
Figure 12.3. Percentage of peritoneal dialysis patients with phosphate within the range specified by the RA clinical audit measure (1.1–1.7 mmol/L) by centre in 2012
![Page 4: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/4.jpg)
UK Renal Registry 16th Annual Report
Figure 12.4. Funnel plot of percentage of peritoneal dialysis patientswith phosphate within the range specified by the RA clinical audit
measure (1.1–1.7 mmol/L) by centre in 2012
![Page 5: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/5.jpg)
UK Renal Registry 16th Annual Report
Figure 12.5. Longitudinal change in percentage of patients with phosphate below, within and above the
2010 RA standard by dialysis modality 2000–2012
![Page 6: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/6.jpg)
UK Renal Registry 16th Annual Report
Figure 12.6. Percentage of haemodialysis patients with adjusted calcium
within range (2.2–2.5 mmol/L) by centre in 2012
![Page 7: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/7.jpg)
UK Renal Registry 16th Annual Report
Figure 12.7. Funnel plot of percentage of haemodialysispatients with adjusted calcium within range (2.2–2.5
mmol/L)by centre in 2012
![Page 8: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/8.jpg)
UK Renal Registry 16th Annual Report
Figure 12.8. Percentage of peritoneal dialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2012
![Page 9: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/9.jpg)
UK Renal Registry 16th Annual Report
Figure 12.9. Funnel plot of percentage of peritoneal dialysis patients with adjusted calcium within range (2.2–2.5 mmol/L) by centre in 2012
![Page 10: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/10.jpg)
UK Renal Registry 16th Annual Report
Figure 12.10. Longitudinal change in percentage of patients with adjusted calcium <2.2 mmol/L, 2.2–2.5 mmol/L and
>2.5 mmol/L by dialysis modality 2002–2012
![Page 11: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/11.jpg)
UK Renal Registry 16th Annual Report
Figure 12.11. Percentage of haemodialysis patients with PTH within range (16–72 pmol/L) by centre in 2012
![Page 12: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/12.jpg)
UK Renal Registry 16th Annual Report
Figure 12.12. Funnel plot of percentage of haemodialysis patients with PTH within range (16–72 pmol/L) by centre in 2012
![Page 13: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/13.jpg)
UK Renal Registry 16th Annual Report
Figure 12.13. Percentage of peritoneal dialysis patients with PTH within range (16–72 pmol/L) by centre in 2012
![Page 14: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/14.jpg)
UK Renal Registry 16th Annual Report
Figure 12.14. Funnel plot of percentage of peritoneal dialysispatients with PTH within range (16–72 pmol/L) by centre in 2012
![Page 15: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/15.jpg)
UK Renal Registry 16th Annual Report
Figure 12.15. Percentage of HD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2012
![Page 16: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/16.jpg)
UK Renal Registry 16th Annual Report
Figure 12.16. Percentage of PD patients achieving simultaneous control of all three BMD parameters in preventing severe hyperparathyroidism by centre in 2012
![Page 17: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/17.jpg)
UK Renal Registry 16th Annual Report
Figure 12.17. Funnel plot for percentage of HD patients achievingsimultaneous control of all three BMD parameters in preventing
severe hyperparathyroidism by centre in 2012
![Page 18: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/18.jpg)
UK Renal Registry 16th Annual Report
Figure 12.18. Funnel plot for percentage of PD patients achieving simultaneous control of all three BMD parameters in preventing
severe hyperparathyroidism by centre in 2012
![Page 19: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/19.jpg)
UK Renal Registry 16th Annual Report
Figure 12.19. Funnel plot for percentage of haemodialysis patientswithin the range for bicarbonate (18–24 mmol/L) by centre in 2012
![Page 20: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/20.jpg)
UK Renal Registry 16th Annual Report
Figure 12.20. Funnel plot for percentage of peritoneal dialysis patients within the range for bicarbonate (22–30 mmol/L) by centre in 2012
![Page 21: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/21.jpg)
UK Renal Registry 16th Annual Report
Figure 12.21. Median total cholesterol in haemodialysis patients by centre in 2012
![Page 22: UK Renal Registry 16th Annual Report Figure 12.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit](https://reader035.vdocuments.net/reader035/viewer/2022062805/5697bfd71a28abf838cae925/html5/thumbnails/22.jpg)
UK Renal Registry 16th Annual Report
Figure 12.22. Median total cholesterol in peritoneal dialysis patients by centre in 2012